Telix Pharma
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy 2022-11-22 04:59
Telix Acquires Optimal Tracers 2022-11-14 06:36
Telix to Present at Jefferies London Healthcare Conference 2022 2022-11-11 20:00
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study 2022-11-07 06:48
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022 2022-10-27 10:23
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide 2022-10-27 06:44
Telix Reports Third Quarter 2022 Financial Results 2022-10-20 06:09
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM 2022-10-18 06:43
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market 2022-10-17 13:00
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging 2022-10-17 07:25
Health Canada Approves Illuccix® for Prostate Cancer Imaging 2022-10-14 08:21
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent 2022-09-30 02:30
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate 2022-09-28 06:50
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent 2022-09-28 05:00
First Patient Enrolled in ProstACT TARGET Study 2022-09-27 05:00
Final IPAX-1 Study Data Confirms Safety and Tolerability Profile for TLX101, Preliminary Efficacy Data 2022-09-21 07:51
Targeted Alpha Therapy Candidate: Bladder Cancer Study Completes Enrolment 2022-08-24 05:56
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant 2022-08-08 07:55
Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging 2022-08-02 06:54
BAMF Health and Telix complete first total-body PET scans with Illuccix for prostate cancer imaging 2022-07-27 20:30
1 2 3 4 5 6 6